Loading clinical trials...
Loading clinical trials...
This is a pilot proof-of-concept randomized controlled trial, open-label and unblinded, examining the feasibility and acceptability of Buprenorphine extended-release vs. daily sublingual buprenorphine...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
NYU Langone Health
Collaborators
NCT06574009 · Chronic Pain, Cancer Survivor, and more
NCT05463367 · Opioid Use, Opioid Dependence, and more
NCT03345173 · Opioid Dependence
NCT03155906 · Hepatitis C, Chronic, Opioid Dependence, on Agonist Therapy
NCT04454411 · Opioid Dependence
Bellevue Hospital Center
New York, New York
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions